Detalhe da pesquisa
1.
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial.
Lancet
; 390(10094): 555-566, 2017 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28600132
2.
Sequence analysis of ß-subunit genes of the 20S proteasome in patients with relapsed multiple myeloma treated with bortezomib or dexamethasone.
Blood
; 120(23): 4513-6, 2012 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-23018640
3.
Tumor cell SYK expression modulates the tumor immune microenvironment composition in human cancer via TNF-α dependent signaling.
J Immunother Cancer
; 10(7)2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35868661
4.
Response to brentuximab vedotin versus physician's choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis.
Eur J Cancer
; 148: 411-421, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33794441
5.
Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris.
J Exp Med
; 199(1): 125-30, 2004 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-14707118
6.
Consistent expression of guanylyl cyclase-C in primary and metastatic gastrointestinal cancers.
PLoS One
; 12(12): e0189953, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29261789
7.
Use of the Total Cancer Care System to Enrich Screening for CD30-Positive Solid Tumors for Patient Enrollment Into a Brentuximab Vedotin Clinical Trial: A Pilot Study to Evaluate Feasibility.
JMIR Res Protoc
; 6(3): e45, 2017 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28320689
8.
Transcriptional profiles in peripheral blood mononuclear cells prognostic of clinical outcomes in patients with advanced renal cell carcinoma.
Clin Cancer Res
; 11(3): 1181-9, 2005 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15709187
9.
Clinical pharmacogenomics and transcriptional profiling in early phase oncology clinical trials.
Curr Mol Med
; 5(1): 83-102, 2005 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15720272
10.
Disease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma.
Cancer Res
; 63(18): 6069-75, 2003 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-14522937
11.
Understanding the Supersensitive Anti-Drug Antibody Assay: Unexpected High Anti-Drug Antibody Incidence and Its Clinical Relevance.
J Immunol Res
; 2016: 3072586, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27340678
12.
A single administration of recombinant human interleukin-12 is associated with increased expression levels of interferon-gamma and signal transducer and activator of transcription in healthy subjects.
J Clin Pharmacol
; 45(6): 649-58, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15901746
13.
Exploiting genotypic differences to identify genes important for EAE development.
J Neurol Sci
; 239(1): 81-93, 2005 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16214174
14.
Development of a Drug-Response Modeling Framework to Identify Cell Line Derived Translational Biomarkers That Can Predict Treatment Outcome to Erlotinib or Sorafenib.
PLoS One
; 10(6): e0130700, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26107615
15.
Interleukin-11. A gp130 cytokine.
Ann N Y Acad Sci
; 856: 12-21, 1998 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-9917860
16.
Narrowband (312-nm) UV-B suppresses interferon gamma and interleukin (IL) 12 and increases IL-4 transcripts: differential regulation of cytokines at the single-cell level.
Arch Dermatol
; 139(2): 155-61, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12588221
17.
Interleukin-11 inhibits NF-kappaB and AP-1 activation in islets and prevents diabetes induced with streptozotocin in mice.
Exp Biol Med (Maywood)
; 229(5): 425-36, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15096655
18.
Validation of a flow cytometry based G(2)M delay cell cycle assay for use in evaluating the pharmacodynamic response to Aurora A inhibition.
J Immunol Methods
; 363(2): 135-42, 2011 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-20887727
19.
Pharmacogenomic data submissions to the FDA: clinical case studies.
Pharmacogenomics
; 5(5): 519-24, 2004 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15212589
20.
A randomized phase 2 study of erlotinib alone and in combination with bortezomib in previously treated advanced non-small cell lung cancer.
J Thorac Oncol
; 4(8): 1002-9, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19633475